medical device investing Knight Therapeutics Announces Health Canada Approval for JORNAY PM to Treat Attention-Deficit Hyperactivity Disorder 14 November 2024
medical device investing Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call 31 October 2024
